Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
þ
No
¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $1,706,843 on June 30, 2017.
Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. 69,016,468 shares of common stock are outstanding as of April 9, 2018.
Certain statements in this annual report contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause our actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to:
our history of losses and uncertainty that we will be able to continue as a going concern,
our need for additional financing and uncertainties related to our ability to obtain these funds,
our ability to repay the outstanding debt of approximately $7,963,349 at December 31, 2017 due our Chairman and CEO which matures on December 31, 2018,
the significant amount of deferred compensation owed to two of our executive officers and one other employee and our ability to pay these amounts,
our ability to protect our intellectual property, and the potential impact of expiring patents on our business in future periods,
anti-takeover provisions of Delaware law and our Board's ability to issue preferred stock without stockholder consent,
potential dilution to our stockholders from the exercise of outstanding options and warrants,
Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements and readers should carefully review this annual report in its entirety, including the risks described in
Part I. Item 1A. Risk Factors
. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this annual report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.
When used in this annual report, the terms "Puradyn", the “Company,” "we," "our," and "us" refers to Puradyn Filter Technologies Incorporated, a Delaware corporation. “2017” refers to the year ended December 31, 2017, “2016” refers to the year ended December 31, 2016, and “2018” refers to the year ending December 31, 2018.
PART I
ITEM 1.
BUSINESS.
The Company
We design, manufacture, market and distribute worldwide the Puradyn® bypass oil filtration system (the
"Puradyn" or “system”
) for use with substantially all internal combustion engines and hydraulic equipment that use lubricating oil. Working in conjunction with the equipment’s full-flow oil filter, the
Puradyn
system cleans oil by providing a second circuit of oil filtration and treatment to continually remove solid, liquid and gaseous contaminants from the oil through a sophisticated and unique filtration and evaporation or absorption process. The
Puradyn
system consists of a base filtration unit or housing that is connected via hoses to the engine or hydraulic system, along with filter elements that reside inside the filtration unit and are replaced periodically to maintain top performance. Our filter is unique in that it incorporates an additive package to replenish depleted base additive levels in engine lubricating oil. Because
Puradyn
-filtered lubricating oil is kept in a continually clean state, our system
has been used effectively to safely and significantly extend oil-drain intervals and to extend the time between engine overhauls. We are the exclusive manufacturer of our unique disposable replacement filter elements ("Element") for the
Puradyn
system.
Products
The core product, the patented
Puradyn
bypass oil filtration system, is offered in two models, MTS and a custom-engineered hydraulic system, which can be attached to almost any engine or hydraulic application. The Puradyn bypass filtration system is similar to a kidney dialysis machine that provides an additional filtration circuit outside the body/engine to filter blood/oil and rid it of impurities, keeping the blood/oil continually clean. Whenever the engine or machinery is operating, the
Puradyn
is extracting from the oil solid particles down to less than one micron (1/39 millionth of an inch), as well as gaseous and liquid contaminants, protecting the engine or hydraulic equipment from harmful wear and less efficient operation caused by these contaminants.
Puradyn
replacement filter elements may contain an additive package that serves to replenish base additives (in engine lube oil only) in the oil during the filtration process, helping to maintain the oil’s proper chemical balance and viscosity.
Oil condition is monitored through periodic analysis of small oil samples. If the sample results show that the condition of the oil is considered good for continued use, the
Puradyn
filter element is changed in lieu of performing a scheduled oil change.
Consequently, the
Puradyn
system significantly reduces maintenance costs by decreasing oil consumption, engine wear and certain other types of general maintenance as well as reducing environmental impact and concerns and costs associated with the storage and disposal of waste oil. Depending on the application, potential savings from utilizing the
Puradyn
system generally provide a relatively short average payback period of 3 to 12 months, during which time the customer’s oil and labor savings more than recoup the cost of the filtration unit and expended filter elements.
The MTS System is offered in seven different-sized systems that can be used in single or multiple configurations to effectively filter sizes from small (4 qt. / 3.8 L) to large (510 gal. / 1930.50 L) sump capacity engines, allowing the product to be used virtually on most engines in every industry. The MTS model offers water contaminant removal through the Company’s patented Polydry
®
polymer technology embedded in each filter element.
The hydraulic filtration system provides the same filtration efficiency and ability to remove water and solid particles as our engine filtration systems and is capable of handling hydraulic fluids with capacities up to 1,500 gallons (5,678 liters). Certain hydraulic filtration systems being developed now will easily adapt to other industries where our systems are already operating in engine lube applications.
All
Puradyn
systems are compatible with virtually all standard and synthetic oils on the market, and they work with engines using gasoline, diesel, propane or natural gas. The
Puradyn
system, ordinarily, cannot be used on engines that do not have a pressurized lubricating system.
We are also the sole manufacturer and provider of replacement filter elements for the
Puradyn
system. Depending upon the application, we generally recommend that the element be replaced at the engine manufacturer's recommended/approved periodic oil change interval or current service interval. The type of element used also depends upon the specific type of engine or hydraulic application. A customer can change the filter element and take the required oil sample in approximately five to 10 minutes.
1
The
Puradyn
system
has no moving parts and consequently requires no significant ongoing maintenance. As long as filter elements are changed at the recommended intervals and other standard preventive maintenance procedures are completed, such as changing factory full-flow oil filters and air filters and completing regular oil analyses, the Company believes the
Puradyn
system
will perform as designed; such belief is established and supported by historical field performance over more than two decades.
Warranties
The
Puradyn
system
carries a six-month ‘money-back’ performance guarantee and is currently warrantied to the original user to be free of defects in material and workmanship for five years from date of purchase, with a one-year limited warranty on the heating element contained in the legacy PFT models. The Company will accept returns of products that are defective at the time of sale or prove to be defective during the limited warranty period. Returns are subject to specific conditions.
For the Company’s performance guarantee and warranty to remain in effect, users must, among other things, maintain a record of the laboratory oil analysis results and use
Puradyn
filter elements and replacement parts. The Company has received letters from numerous OEMs which have all stated that the installation and use of the
Puradyn
system
does not void their manufacturer warranties if there is no oil related engine failure or malfunction attributed to the
Puradyn
system. To date, there have been no significant warranty claims, although there can be no assurances that such a trend will continue.
Marketing
The Company has an in-house marketing department comprised of two employees, with various projects outsourced on an as-needed basis. In December 2017, the Company added an outside strategic advisor who also acts in the capacity of marketing consultant.
The Company’s products are marketed to numerous industries that include hydraulic applications, and other users of engines or equipment that utilize up to 50 weight oil for lubrication. Additionally, we offer marketing assistance in material development to distributors.
Distribution
We currently have a network of over 45 domestic and international distributors and dealers; however, the majority of our products are sold through a limited number of distributors. Our distributors and dealers sell products to a number of industries, including oil and gas services, power generation, construction and forestry, commercial marine, mining, and transportation. Currently, international sales are administered by Puradyn from the United States. The international distributors are located in South America, Europe, the Middle East, and Asia. Our international distributors purchase product directly from the Company and sell to their existing or new customers. All distributor agreements can be terminated by either party with a 30 to 60 day written notice.
In February 2018 we entered into a second amendment to our September 2017 amended distribution agreement with DNOW LP (DNOW), a distributor with approximately 300 outlets worldwide that have the potential to sell and service the
Puradyn
system. Under the terms of the amended distribution agreement with DNOW, we granted it exclusive distribution agreement for the worldwide rights to sell our product in the oil and gas industry effective September 7, 2017. An incentive program is used to incentivize and compensate the distributor for reaching certain sales thresholds. The incentive is the difference between the price of product currently being charged by the Company offered to this distributor for the oil and gas industry and the applicable distributor price currently available. The incentive, in the form of credits toward future product, is redeemable only if targeted quarterly goals are achieved. If the goals are not achieved the credits will be carried forward and are redeemable when the cumulative quarterly and/or total goals are achieved. The incentive pricing program expires in December 2018. Targeted quarterly goals, if achieved, represent an aggregate of approximately $4 million in potential sales revenue between August 1, 2017, and June 30, 2018. Sales under the agreement, however, amounted to $558,141 for the period from August 1, 2017 to December 31, 2017 which was approximately 31% below the targeted revenue goals for the period.
2
Sales
Direct Sales
The Company directly and/or with the assistance of its manufacturer's representatives, distributors, or other agents, markets its products directly to OEMs, other distributors and national accounts. We are dependent upon sales from a limited number of customers. During 2017, three customers together accounted for 64% of the Company’s net sales, and in 2016 three customers together accounted for 57% of the Company’s net sales. There were two customers at December 31, 2017, whose trade receivable balances equaled or exceeded 10% of total receivables, representing approximately 53%, and 30% respectively of total receivables, none of which are past due. There were three customers at December 31, 2016, whose trade receivable balances equaled or exceeded 10% of total receivables, representing approximately 50%, 18% and 13%, respectively of total receivables, none of which are past due.
The loss of business from one or a combination of the Company’s significant customers could adversely affect its operations.
On November 17, 2017, the Company received two non-binding purchase orders from a major oil and gas customer for delivery of Puradyn product in shipments ranging from December 2017 to September 2018. The expected revenue to us to be generated from this sale will be approximately $1,000,000; this oil and gas customer’s purchases, although made directly with Puradyn, will be credited to the targeted quarterly goals attributable to the agreement with DNOW to sell exclusively to the oil and gas industry. Although there is a commitment by all parties to fulfill the orders, the purchase orders can be cancelled at any time by the customer prior to shipment and, accordingly, there are no assurances these sales will be made. As of December 31, 2017 we have shipped a total of $123,918.
International Sales
The Company, directly and/or with the assistance of commission-based manufacturer's representatives, has established primarily non-exclusive distributors and sales representation in various countries, including the Middle East, Germany, Romania, Turkey, United Kingdom, Thailand, Colombia, and others. The ultimate success of these and other distributors primarily depends upon their ability to successfully introduce and sell the product in their respective territories, including obtaining local evaluations, establishing distribution, and other factors similar to those faced by the Company in the United States. Unlike domestic sales, the Company has a policy that international sales be paid in advance or secured by a letter of credit before shipping. The Company’s credit risk is minimal with international sales as a result of this policy. Total international sales amounted to approximately 25.3% and 34.7% of net sales in 2017 and 2016, respectively.
Manufacturing and Production
The Company purchases component parts for unit housings and filter elements. The component parts are assembled, packed and shipped from our facility in Boynton Beach, Florida.
We currently source a majority of our raw materials and component parts from various vendors in the United States, and actively search for suppliers that are based in the United States. Substantially all the tools and dies used by certain of our vendors are owned by the Company. We have researched alternative sources of supply and do not anticipate that the loss of any single supplier would have a material long-term adverse effect on our business, operations or financial condition. However, there can be no assurance that our current or future suppliers will be able to meet our requirements on commercially reasonable terms or within scheduled delivery times. An interruption of our arrangements with suppliers could cause a delay in the production of our products for timely delivery to distributors and customers which could result in a loss of sales revenue in future periods. The Company has achieved ISO 9001:2015 registration from the International Organization for Standardization, validating its Quality Management Standards process for ‘design, manufacture, sales and distribution of bypass oil filtration systems and replacement filters for various industries.’
Engineering and development costs are expensed as incurred. During the years ended December 31, 2017 and 2016, we incurred engineering and development costs, excluding payroll and benefit expenses for engineering, in the amount of $6,981 and $9,068, respectively, which are included in selling and administrative expenses in the accompanying statements of operations
.
3
Competition
Bypass oil filtration systems produced by other companies in varying degrees address the issues of solid or liquid contaminant filtration through centrifugal design, media filtration or evaporation. However, Puradyn believes that its solution is the only bypass oil filtration system that simultaneously incorporates all of the following features, which provide us with a competitive advantage:
·
Filtering solid contaminants to below one micron, including enhanced soot retention through the use of a patent-pending process for chemical grafting;
·
Effectively removing harmful gaseous and liquid contaminants through a heated evaporation chamber or patented polymer formulation; and
·
Replenishing the base additives in engine oil so as to maintain proper oil viscosity and total base number (TBN) rating.
The proper use of our products reduces the need for oil-related maintenance services, replacement parts, original oil sales and consumption and waste oil disposal.
Some of our competitors may have more capital, greater brand recognition, larger customer bases and significantly greater financial, technical and marketing resources than we do. Our competitors' products may achieve greater acceptance in the marketplace than our own, limiting our ability to gain market share and customer loyalty and to generate sufficient revenues to achieve a profitable level of operations.
Intellectual Property
Our ability to compete effectively depends in part on our ability to maintain the proprietary nature of our technology, products and manufacturing processes. We principally rely upon patent, trademark, trade secrets and contract law to establish and protect our proprietary rights.
We rely on a combination of trade secrets, patents and trademarks to establish and protect our intellectual property rights. As of December 31, 2017, we had issued seven U.S. patents and 22 issued international patents that directly relate to our technology that expire between 2017 and 2033, as well as one pending patent application in the U.S. and 48 pending patent applications internationally.
Subject to the availability of sufficient working capital, we expect to pursue additional patent protection to the extent that we believe it would be beneficial and cost effective.
In 2017 and 2016 we spent $6,981 and $9,068, respectively, on engineering and development.
We have registered the product trademark “
Puradyn
®
”
in the United States and other countries where the "
Purifiner
®
" trademark was registered, and have also registered the trademarks
“Polydry
®
”
, “
CGP
®
”
,
“Keep It Clean!
®
”, “We Fight Dirty
®
”, Let’s Talk Dirty
®
”, and the Puradyn logo
in the United States and targeted countries.
We have also obtained the rights to the domain name www.puradyn.com as well as the domain names puradyn.asia, puradyn.ro, puradyn.com.tr, puradyn.org, puradyn.us, puradyn.info and puradyn.biz. As with telephone numbers, we do not have and cannot acquire any property rights in an Internet address. We do not expect to lose the ability to use these Internet addresses; however, there can be no assurance in this regard.
Employees
At March 30, 2018, the Company had 20 full-time employees and one part-time employee, including our executive officers.
Our employees are not covered by collective bargaining agreements, and we believe our relationship with our employees to be good.
History of our Company
The Company has been incorporated in the State of Delaware since February 1988. On February 4, 1998, the Company filed a Certificate of Amendment to its Certificate of Incorporation, changing its name to Puradyn Filter Technologies Incorporated.
4
ITEM 1A.
RISK FACTORS.
An investment in our common stock involves a significant degree of risk. You should not invest in our common stock unless you can afford to lose your entire investment. You should consider carefully the following risk factors and other information in this annual report before deciding to invest in our common stock. If any of the following risks and uncertainties develops into actual events, our business, financial condition or results of operations could be materially adversely affected and you could lose your entire investment in our Company.
Risks Related to our Business
WE HAVE A HISTORY OF LOSSES AND OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM HAS SUBSTANTIAL DOUBTS ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN.
We have incurred substantial operating and net losses, as well as negative operating cash flows, since our inception through December 31, 2017. For the years ended December 31, 2017 and 2016, we reported net losses of $1,230,094 and $1,441,217, respectively, and at December 31, 2017 we had a working capital deficit of $9,470,970. At December 31, 2017, we had an accumulated deficit of approximately $62.6 million. These recurring losses, working capital deficit and the reliance on cash inflows from related parties have led our independent registered public accounting firm to include a statement in its audit report relating to our audited financial statements for the years ended December 31, 2017 and 2016 expressing substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty. We anticipate that we will continue to incur losses in future periods until we are successful in significantly increasing our revenues. There are no assurances that we will be able to raise our revenues to a level which supports profitable operations and provides sufficient funds to pay our obligations. If we are unable to meet those obligations, we could be forced to cease operations in which event investors would lose their entire investment in our Company.
WE NEED ADDITIONAL FINANCING WHICH WE MAY NOT BE ABLE TO OBTAIN ON ACCEPTABLE TERMS. IF WE CANNOT RAISE ADDITIONAL CAPITAL AS NEEDED, OUR ABILITY TO FUND OUR ONGOING OPERATIONS WILL BE IN JEOPARDY AND WE WILL BE UNABLE TO CONTINUE AS A GOING CONCERN.
As described elsewhere herein, our net sales are not sufficient to pay our operating expenses. Our capital requirements depend on a number of factors, including our ability to internally grow our revenues, manage our business and control our expenses. Historically, our operations have been financed primarily through a credit line from our Chief Executive Officer, as well as short-term loans from other affiliates. At December 31, 2017, we owe him approximately $8 million which is due in December 2018. Earlier in 2017 he advised us that he does not expect to continue to provide working capital advances to the Company at historic levels, if at all. During 2017, he lent us a total of $875,000 as compared to $1,363,732 in 2016. From January 1, 2018 through April 9, 2018, he has lent us an additional $200,000. The reductions in the amount of advances to us from our Chief Executive Officer have adversely impacted our operations from time to time. While we do not have any external sources of liquidity at this time, the Company is in continuing discussion with third parties for potential investment. These historic discussions, however, have not resulted in identifying any potential capital raising transactions which were upon proposed terms which we believed were fair to our Company and our stockholders. Given our history of losses and debt levels, we expect to continue to face a number of challenges in our ability to raise capital. If we do not raise funds as needed, or if our Chief Executive Officer should continue to reduce amounts advanced to us or discontinue altogether his practice of advancing funds to us to pay our operating expenses, our ability to provide for current working capital needs, pay our obligations as they become due, grow our Company, and continue our existing business and operations is in jeopardy. In this event, we would no longer be able to continue as a going concern and you could lose all of your investment in our Company.
OUR NET SALES INCREASED IN 2017 FROM 2016 BUT ARE NOT SUFFICIENT TO FUND OUR OPERATING EXPENSES. THERE ARE NO ASSURANCES WE WILL BE ABLE TO INCREASE OUR SALES, IN THE NEAR FUTURE, TO A LEVEL WHICH WILL FUND OUR OPERATING EXPENSES.
Although our net sales for 2017 increased by 16% from 2016, our current operations remain insufficient to fund our operating expenses and pay our obligations as they become due. We used cash in operations of approximately $703,037 and $1,268,730 in 2017 and 2016, respectively. Our gross margins have also declined in 2017 from 2016 by approximately 3% as a result of certain fixed costs which are included in our cost of sales. As long as our cash flow from operations remains insufficient to fund our operations, we will continue depleting our cash and other financial resources, which are extremely limited. Our failure to achieve profitable operations in future periods will adversely affect our ability to continue as a going concern. In this event, you could lose all of your investment in our Company.
5
WE ARE DEPENDENT UPON SALES TO A LIMITED NUMBER OF CUSTOMERS AND ONE EXCLUSIVE DISTRIBUTOR REPRESENTING THE OIL AND GAS INDUSTRY. THERE ARE NO ASSURANCES THIS DISTRIBUTOR WILL MEET THE TARGETED SALES GOALS.
In September 2017 we granted DNOW exclusive worldwide rights to sell our products in the oil and gas industry effective September 7, 2017. Under the terms of the agreement as amended in February 2018, sales to all customers in the oil and gas industry have been attributed to DNOW targeted sales goals. Targeted quarterly goals, if achieved, would represent an aggregate of approximately $4 million in sales revenue between August 1, 2017 and June 30, 2018. This revenue includes any and all purchases made directly or indirectly through Puradyn by any customer servicing the oil and gas industry. Sales under the agreement amounted to $558,141 for the period from August 1, 2017 to December 31, 2017, representing approximately 25% of our total net sales for 2017. However, the sales to DNOW were approximately 31% below the targeted goals for that period and these sales are made at lower gross margins than sales to other customers. There are no binding obligations from DNOW to purchase a certain amount of product from us, nor to undertake any specific marketing or sales incentives related to our products. Historically, sales to the oil and gas industry have represented approximately 70% and 41%, respectively, of our net sales in 2017 and 2016. In 2017, DNOW represented 51% of our total sales into this industry. While we granted DNOW these exclusive rights because we believed its distribution network was broad enough that it could facilitate our growth in this industry, we are wholly dependent upon DNOW’s sales efforts over which we have limited control. There are no assurances it will ever meet the non-binding targeted revenue goals and the exclusive nature of this agreement prevents us from engaging other distributors to facilitate sales of our products in the oil and gas industry. In that event, our revenues may be adversely impacted in future periods.
WE OWE APPROXIMATELY $8 MILLION WHICH IS DUE BY DECEMBER 31, 2018.
At December 31, 2017, we owe our Chief Executive Officer approximately $8 million, and he has advanced us an additional $200,000 through April 9, 2018. This loan, which is unsecured, is due on December 31, 2018 or (i) at such time as we have raised an additional $7 million over the $3.5 million raised in prior offerings, or (ii) at such time as we are operating within sufficient cash flow parameters to sustain operations, or (iii) until a disposition of our Company, such as an acquisition or merger, occurs. We do not have sufficient funds to pay this loan when it becomes due. Although he has continually extended the due date of this obligation since the credit line was first extended to us in 2002, most recently extending the maturity date from December 31, 2017 to December 31, 2018, these extensions were generally provided on an annual basis so to an extended term which made the obligation a long-term debt. There are no assurances this stockholder will continue to provide extension to us prior to the due date. While we have engaged in informal discussions with him regarding a conversion of this amount into equity or outright forgiveness, no formal agreement has been reached and there are no assurances whatsoever that any accommodation on this obligation will be made to us.
WE RELY ON SALES TO A LIMITED NUMBER OF CUSTOMERS AND THERE ARE NO ASSURANCES THAT THESE CUSTOMERS WILL CONTINUE TO PURCHASE PRODUCTS FROM US.
We are dependent upon sales to a limited number of customers. During 2017, three customers individually accounted for approximately 36%, 16% and 12%, respectively (for a total of 64%) of our net sales. During 2016 three customers individually accounted for approximately 24%, 18% and 15%, respectively (for a total of 57%) of our net sales. We do not have contracts with our customers and the loss of sales from one or more of these customers could materially impact our results of operations in future periods.
AT DECEMBER 31, 2017 OUR CURRENT LIABILITIES INCLUDE $1,626,003
OF DEFERRED COMPENSATION. WE DO NOT HAVE THE FUNDS TO PAY THESE AMOUNTS.
Since 2005, Messrs. Sandler and Kroger, two of our executive officers, and one other employee, have deferred a portion of the cash compensation due them to assist us in managing our cash flow and working capital needs. As there is no written agreement with these employees which memorializes the terms of salary deferral, only an election to do so, it is possible that the employees could demand payment in full at any time, elect to no longer defer their salaries, or reduce the amount they currently defer. We do not have the funds to pay these amounts, and unless we are successful in raising additional capital we are unable to satisfy any demands by these officers and employees for full payment of these obligations of which there are no assurances, we would be unable to pay these amounts to our employees. In that event, it is likely we would lose their services in future periods.
6
IF WE ARE UNABLE TO PROTECT OUR INTELLECTUAL PROPERTY OUR ABILITY TO CONDUCT OUR BUSINESS AS IT IS PRESENTLY CONDUCTED IS IN JEOPARDY.
Our success is heavily dependent on our proprietary technology and we rely on a combination of contractual rights, patents, trade secrets, trademarks and non-disclosure agreements to establish and protect our proprietary rights. There can be no assurances that the steps we take to protect our proprietary rights will be adequate to prevent misappropriation of the technology or independent development by others of products with features based upon, or otherwise similar to, our products. In addition, although we believe that any new technology currently in development or patent pending has been independently developed and does not infringe on the proprietary rights of others, there can be no assurance that we are correct or that third parties will not assert infringement claims against us in the future. If instituted, there can be no assurances we will have adequate resources to defend a patent infringement or other proprietary rights infringement action. If we are unable to adequately protect our proprietary rights or if other products should be developed which are substantially similar to ours, our ability to continue our operations as they are presently conducted could be in jeopardy and we could be forced to cease operations. The Company believes it will have future benefits from current patent awards and applications to the extent it has working capital to pursue those patents, of which there is no assurance, and does not regard our business as being dependent upon any single patent or group of patents that may expire in the near-term.
Risk Related to our Common Stock
PROVISIONS OF OUR CERTIFICATE OF INCORPORATION AND BYLAWS MAY DELAY OR PREVENT A TAKE-OVER WHICH MAY NOT BE IN THE BEST INTERESTS OF OUR STOCKHOLDERS.
Provisions of our certificate of incorporation and bylaws may be deemed to have anti-takeover effects, which include when and by whom special meetings of our shareholders may be called, and may delay, defer or prevent a takeover attempt. In addition, certain provisions of the Delaware General Corporation Law also may be deemed to have certain anti-takeover effects. Further, our certificate of incorporation authorizes the issuance of up to 500,000 shares of preferred stock with such rights and preferences as may be determined from time to time by our board of directors in their sole discretion. Although, to date, we have never issued preferred stock, our board of directors may, without stockholder approval, issue series of preferred stock with dividends, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the holders of our common stock.
THE EXERCISE OF OUTSTANDING WARRANTS AND OPTIONS WILL BE DILUTIVE TO OUR EXISTING STOCKHOLDERS.
At December 31, 2017, we had 69,016,468 shares of our common stock issued and outstanding and the following securities, which are exercisable into shares of our common stock, were outstanding:
·
990,162 shares of our common stock issuable upon the exercise of warrants with exercise prices ranging from $0.05 to $0.35 per share; and
·
3,180,000 shares of our common stock issuable upon the exercise of options with exercise prices ranging from $0.026 per share to $0.35 per share.
The issuance of these shares will be dilutive to our existing stockholders.
BECAUSE OUR STOCK CURRENTLY TRADES BELOW $5.00 PER SHARE, AND IS QUOTED ON THE OTCQB® MARKETPLACE, OUR STOCK IS CONSIDERED A "PENNY STOCK" WHICH CAN ADVERSELY AFFECT ITS LIQUIDITY.
As the trading price of our common stock is less than $5.00 per share, our common stock is considered a "penny stock," and trading in our common stock is subject to the requirements of Rule 15g-9 under the Securities Exchange Act of 1934. Under this rule, broker/dealers who recommend low-priced securities to persons other than established customers and accredited investors must satisfy special sales practice requirements. The broker/dealer must make an individualized written suitability determination for the purchaser and receive the purchaser's written consent prior to the transaction.
Securities and Exchange Commission regulations also require additional disclosure in connection with any trades involving a "penny stock," including the delivery, prior to any penny stock transaction, of a disclosure schedule explaining the penny stock market and its associated risks. These requirements severely limit the liquidity of our common stock in the secondary market because few brokers or dealers are likely to undertake these compliance activities. Purchasers of our common stock may find it difficult to resell the shares in the secondary market.
7
THERE MAY NOT BE SUFFICIENT LIQUIDITY IN THE MARKET FOR OUR SECURITIES IN ORDER FOR INVESTORS TO SELL THEIR SECURITIES. THE MARKET PRICE OF OUR COMMON STOCK MAY BE VOLATILE.
While our common stock is quoted on the OTCQB Tier of the OTC Markets, our common stock is thinly traded and should be considered an illiquid investment. The market price of our common stock will likely be highly volatile, as is the stock market in general, and the market for over the counter quoted stocks in particular. Some of the factors that may materially affect the market price of our common stock are beyond our control, such as conditions or trends in the industry in which we operate or sales of our common stock. These factors may materially adversely affect the market price of our common stock, regardless of our performance. In addition, the public stock markets have experienced extreme price and trading volume volatility. This volatility has significantly affected the market prices of securities of many companies for reasons frequently unrelated to the operating performance of the specific companies. These broad market fluctuations may adversely affect the market price of our common stock.
FINRA SALES PRACTICE REQUIREMENTS MAY ALSO LIMIT A STOCKHOLDERS ABILITY TO BUY AND SELL OUR STOCK.
In addition to the penny stock rules promulgated by the SEC, which are discussed earlier in this section, the rules of the Financial Industry Regulatory Authority, Inc. (FINRA) require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative, low-priced securities to their non-institutional customers, broker-dealers must have reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit the ability to buy and sell our stock and have an adverse effect on the market value for our shares.
ITEM 1B.
UNRESOLVED STAFF COMMENTS.
Not applicable to a smaller reporting company.
ITEM 2.
PROPERTIES.
We lease approximately 25,500 square feet of office and warehouse space in Boynton Beach, Florida which serves as our principal executive offices, from an unrelated third party under a lease which expires on July 31, 2019. We pay a base rental of $12,386, which escalates to $13,940 in 2018 and we are responsible for all operating expenses and utilities.
The Company leased a condominium in Ocean Ridge, Florida, on an annual basis, to provide accommodations for Company use, primarily for Mr. Alan Sandler and Mr. Kevin Kroger, executive officers of the Company. The lease, which expired in December 2017, has an annual expense of $8,500 and was not renewed for 2018.
ITEM 3.
LEGAL PROCEEDINGS.
None.
ITEM 4.
MINE SAFETY DISCLOSURES.
Not applicable to our Company.
8
PART III
ITEM 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
Directors and Executive Officers
The following individuals serve as our executive officers and/or members of our Board of Directors:
|
|
|
|
|
|
Name
|
|
Age
|
|
Positions
|
|
Joseph V. Vittoria
|
|
82
|
|
Chairman of the Board of Directors and Chief Executive Officer
|
|
Kevin G. Kroger
|
|
66
|
|
President, Chief Operating Officer and Director
|
|
John S. Caldwell
|
|
73
|
|
Director
|
|
Alan J. Sandler
|
|
79
|
|
Vice President, Chief Administrative Officer and Corporate Secretary
|
Joseph V. Vittoria
was appointed to the Puradyn Board of Directors as Chairman on February 8, 2000 and to the office of Chief Executive Officer on October 24, 2006. Mr. Vittoria was Chairman and Chief Executive Officer of Travel Services International, Inc. from 1997 until it was sold in 2000. From 1987 to 1997, Mr. Vittoria served as Chairman and Chief Executive Officer of Avis, Inc., and was its President and Chief Operating Officer from 1982 to 1987. Mr. Vittoria also serves on the Board of Yachtico.com. He is also an Emeritus Member of the Columbia Business School’s Board of Overseers.
Mr. Vittoria’s extensive management, banking, organizational growth and experience bring oversight and guidance to the Company’s entire organization. The Board believes that Mr. Vittoria has the experience, qualifications, attributes and skills necessary to serve as Chairman.
Kevin G. Kroger
joined Puradyn July 3, 2000 as President and Chief Operating Officer and was appointed to the Board of Directors in November 2000. He was also appointed to the Board of Puradyn Ltd. in December 2000, Mr. Kroger was with Detroit Diesel Corporation from 1989 to the time he joined our Company, serving in various executive and Board positions prior to his appointment in 1998 to the position of Vice President and General Manager of Series 55/40/30/Cento Industrial product line. From 1987 to 1989 he was Vice President of R.E.S. Leasing and of VE Corporation. From 1971 to 1987, he held several management positions with Caterpillar Corporation.
With significant experience in the heavy-duty engine industry, Mr. Kroger provides our company with operations oversight and guidance in sales and marketing. Mr. Kroger also holds a degree in engineering which facilitates our research and development area, along with a deeper understanding in configuring our products to the customer’s needs. The Board believes that Mr. Kroger has the experience, qualifications, attributes and skills necessary to serve as a Director.
Lieutenant General (Retired) John S. Caldwell, Jr
. was appointed to the Puradyn Board of Directors on August 25, 2005 and served as Chairman of the Compensation Committee until it was disbanded in March 2016. Gen. Caldwell served as the Army’s top ranking officer for Acquisition, Logistics and Technology when he retired in January 2004. He also served as Director of the 50,000-person Army Acquisition Workforce, responsible for personnel development and training policy and key assignment recommendations. Prior to these positions, Gen. Caldwell served as the Commanding General of the US Army Tank-Automotive and Armaments Command (TACOM), in which capacity he developed, fielded and supported lethality, survivability and mobility capabilities for approximately 70% of the Army’s ground force. He served 4 years as the Project Manager, Abrams Tank System, leading R&D, production, quality assurance, procurement and logistical support of the Army’s tank program, a $600 million R&D, $15 billion procurement program with major international components. General Caldwell currently consults in various capacities, including as a Member of The Spectrum Group. General Caldwell holds the degrees of Bachelor of Science from the US Military Academy, West Point, in New York; Master in Mechanical Engineering from Georgia Institute of Technology in Atlanta, GA, and the Industrial College of the Armed Forces. General Caldwell served as a member of the board of Taser International from 2007 to May 2016.
Gen. Caldwell’s logistic and military background brings to our organization oversight and guidance in the planning and execution of our financial and operational growth plan. The Board believes that Gen. Caldwell has the experience, qualifications, attributes and skills necessary to serve as a Director.
15
Alan J. Sandler
serves as our Vice President, Chief Administrative Officer, and Secretary to the Board, as our principal financial and accounting officer. Mr. Sandler joined our Company in June 1998 and has served in various other positions including President (June 1998 until January 2000), Chief Operating Officer (June 1998 to January 2000), Chief Financial Officer (June 1998 to March 2001 and August 2001 to March 2002), Principal Financial Officer (April 2010 to present) and Director (June 1998 to December 2004). Prior to joining our Company, from 1995 until 1997 Mr. Sandler served as President and Chief Executive Officer to Hood Depot, Inc., a national restaurant supply manufacturer/distributor. From 1979 to 1995 he was President and Chief Executive Officer of Sandler & Sons Dental Supply Company, a regional dental supply and equipment distributor. Previous to this position he was a Vice President of Gardner Advertising Company, a national advertising agency, from 1965 to 1979.
There are no family relationships between any of the executive officers and directors, except as set forth above. Each director is elected at our annual meeting of stockholders and holds office until the next annual meeting of stockholders, or until his successor is elected and qualified.
If any director resigns, dies or is otherwise unable to serve out his or her term, or if the Board increases the number of directors, the Board may fill any vacancy by a vote of a majority of the directors then in office, although less than a quorum exists. A director elected to fill a vacancy shall serve for the unexpired term of his or her predecessor. Vacancies occurring by reason of the removal of directors without cause may only be filled by vote of the stockholders.
Compliance With Section 16(a) of the Exchange Act
Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to us under Rule 16a-3(d) of the Securities Exchange Act of 1934 during the year ended December 31, 2017 and Forms 5 and amendments thereto furnished to us with respect to the year ended December 31, 2017, as well as any written representation from a reporting person that no Form 5 is required, we are not aware of any officer, director or 10% or greater stockholder that failed to file on a timely basis, as disclosed in the aforementioned Forms, reports required by Section 16(a) of the Securities Exchange Act of 1934 during the year ended December 31, 2017.
Code of Ethics
We have adopted a Business Ethics and Conflicts of Interest Statement outlining business ethics and conflicts of interest for all officers, directors and employees of the Company, including procedures for prompt internal reporting of violations of the code to the appropriate persons.
You will find a copy of our Business Ethics and Conflicts of Interest Statement posted on our website at
http://www.puradyn.com
under Investor Relations, or you may write to us at Puradyn Investor Relations, 2017 High Ridge Road, Boynton Beach, FL 33426. Our Code of Ethics applies to all directors, officers and employees. We will provide a copy to you upon request at no charge.
Board Leadership Structure and the Role of our Board in Risk Oversight
The Board of Directors oversees our business affairs and monitors the performance of management. One of our three directors is independent and we do not have a lead independent director. In accordance with our corporate governance principles, our independent director does not involve himself in day-to-day operations. The independent director keeps informed through discussions with our Chief Executive Officer and our other executive officers, and by reading the reports and other materials that we send them and by participating in meeting of the Board of Directors. Our independent director may meet at any time in his sole discretion without any other directors or representatives of management present. Our independent director has access to the members of our management team or other employees as well as full access to our books and records. We have no policy limiting, and exert no control over, meetings of our independent directors. Our Board of Directors believes our current structure provides independence and oversight and facilitates the communication between senior management and the Board of Directors regarding risk oversight, which the Board believes strengthens its risk oversight activities.
Risk is inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including liquidity risk, operational risk, strategic risk and reputation risk. Management is responsible for the day-to-day management of the risks we face, while the Board, as a whole, has responsibility for the oversight of risk management. In his role and as independent director, General Caldwell meets regularly with management to discuss strategy and risks we face and to address any questions or concerns they may have on risk management and any other matters.
16
Nominees the Board of Directors
We do not have a policy regarding the consideration of any director candidates which may be recommended by our stockholders, including the minimum qualifications for director candidates, nor has our Board of Directors established a process for identifying and evaluating director nominees. We have not adopted a policy regarding the handling of any potential recommendation of director candidates by our stockholders, including the procedures to be followed. Our Board has not considered or adopted any of these policies as we have never received a recommendation from any stockholder for any candidate to serve on our Board of Directors. We do not anticipate that any of our stockholders will make such a recommendation in the near future. While there have been no nominations of additional directors proposed, in the event such a proposal is made, all members of our Board will participate in the consideration of director nominees.
Committees of the Board of Directors
We do not have any committees of comprised of members of our Board of Directors, including an Audit Committee, a Compensation Committee or a Nominating Committee, any committee performing a similar function. The functions of those committees are being undertaken by Board of Directors as a whole. None of our directors is an “audit committee financial expert” within the meaning of Item 401(e) of Regulation S-K. In general, an “audit committee financial expert” is an individual member of the audit committee or board of directors who:
|
|
|
|
|
·
|
understands generally accepted accounting principles and financial statements,
|
|
|
·
|
is able to assess the general application of such principles in connection with accounting for estimates, accruals and reserves,
|
|
|
·
|
has experience preparing, auditing, analyzing or evaluating financial statements comparable to the breadth and complexity to our financial statements,
|
|
|
·
|
understands internal controls over financial reporting, and
|
|
|
·
|
understands audit committee functions.
|
Our securities are not quoted on an exchange that has requirements that a majority of our Board members be independent and we are not currently otherwise subject to any law, rule or regulation requiring that all or any portion of our board of directors include “independent” directors, nor are we required to establish or maintain an Audit Committee or other committee of our Board of Directors.
ITEM 11.
EXECUTIVE COMPENSATION.
The following table summarizes all compensation recorded by us in the last completed fiscal year for:
·
our principal executive officer or other individual serving in a similar capacity, and
·
our two most highly compensated executive officers other than our principal executive officer who were serving as executive officers at December 31, 2017.
For definitional purposes in this annual report these individuals are sometimes referred to as the "named executive officers." The value attributable to any option awards is computed in accordance with FASB ASC 718,
Compensation-Stock Compensation
. During 2017, two executives deferred 15% and 55% of base wages. During 2016, two executives deferred 14% and 29% of base wages. The amounts included below reflect wages actually earned during the respective periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUMMARY COMPENSATION TABLE
|
|
Name and principal position
|
|
Year
|
|
Salary
($)
|
|
Bonus
($)
|
|
Stock
Awards
($)
|
|
Option
Awards
($)
|
|
Non-Equity
Incentive Plan
Compensation
($)
|
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
|
All
Other
Compensation
($)
|
|
Total
($)
|
|
Joseph V. Vittoria
1
|
|
2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
2016
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kevin Kroger
2
|
|
2017
|
|
186,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
14,125
|
|
200,125
|
|
|
|
2016
|
|
186,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
16,135
|
|
202,135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alan Sandler
3
|
|
2017
|
|
112,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
112,000
|
|
|
|
2016
|
|
112,000
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
112,000
|
———————
1.
Mr. Vittoria, who is also the Chairman of our Board of Directors, serves as our Chief Executive Officer. Mr. Vittoria’s compensation excludes interest paid to him under the working capital loan he provides to our Company. See Item 13.
Certain Relationships and Related Transactions, and Director Independence
appearing later in this report.
17
2.
Mr. Kroger serves as our President and Chief Operating Officer. All Other Compensation in the foregoing table represents the aggregate dollar amount of a car allowance received by Mr. Kroger during each fiscal year and disability and life insurance premiums we pay on his behalf. Annual salary deferral of $28,533 and $26,445, is included in his salary for 2017 and 2016, respectively, in the foregoing table. As there is no written agreement with Mr. Kroger which memorializes the terms of salary deferral, only an election to do so, it is possible that he could demand payment in full at any time, elect to no longer defer his salary, or reduce the amount he currently defers.
3.
Mr. Sandler serves as our principal financial and accounting officer, Vice President, and Chief Administrative Officer. All Other Compensation in the foregoing table represents the amounts for reimbursement of health care premiums provided in the same percentage amount as to all employees. Annual salary deferral of $62,000 and $32,000 is included in his salary for 2017 and 2016, respectively, in the foregoing table. As there is no written agreement with Mr. Sandler which memorializes the terms of salary deferral, only an election to do so, it is possible that he could demand payment in full at any time, elect to no longer defer his salary, or reduce the amount he currently defers.
How our Executive Officers Compensation is Determined
Mr. Vittoria, who has served as our Chief Executive Officer since October 2006, is not a party to an employment agreement with the Company. He receives no compensation and does not participate in any of the Company’s insurance plans.
On July 3, 2000, the Company entered into an employment agreement, with an initial term of three years, with Mr. Kroger, who serves as our President and Chief Operating Officer. Thereafter, the contract was amended on December 23, 2002 and July 3, 2003. The term of the agreement automatically renews on a year to year basis on the same terms and conditions contained herein in effect as of the time of renewal. The contract initially provided for an annual salary of $166,000, minimum bonuses of $50,000, $80,000 and $80,000, respectively, for the years 2000 through 2002; 300,000 qualified stock options; a one-year salary severance clause, and certain insurance and auto allowance compensations. Mr. Kroger is also entitled to pay health insurance, a life insurance and disability policy, a $1,000 per month car allowance, five weeks paid vacation and other executive benefits which may be made available from time to time. Upon entering into the agreement we granted Mr. Kroger 10-year options to purchase 300,000 shares of our common stock at the then fair market value of our common stock which vested in equal installments on the first, second, third and fourth anniversary date of the agreement. The agreement also contains customary indemnification, non-compete, confidentiality and invention assignment clauses. The term of the agreement continues on a year-to-year basis on the same terms and conditions as were in effect at the time of renewal. The agreement may be terminated by us upon Mr. Kroger’s death or disability, by us for good cause as defined in the agreement, or by either party without cause. In the event the agreement is terminated on Mr. Kroger’s death, by us for cause or by him without cause, we do not owe any severance benefits. If the agreement is terminated as a result of his disability, we are required to pay him a lump sum equal to the greater of the base salary then in effect for the remaining term of the agreement or for one year. If the agreement is terminated by us without cause or by Mr. Kroger in the event of a change of control of our Company, we are required to pay him a lump sum equal to the greater of the base salary then in effect for the remaining term of the agreement or for one year, together with any declared but unpaid bonus. The addendum dated July 3, 2003 discontinued the bonus provision of the contract but all other terms and conditions of the contract remain in effect.
On November 16, 2017 we entered into an addendum with Mr. Kroger pursuant to which the amount of his life insurance policy was reduced, but all other terms and conditions of the contract remain in effect. During 2017 and 2016, Mr. Kroger’s base annual salary was $186,000 with approximately $28,533 and $26,445, or 15% and 14%, respectively, deferred annually. As there is no written agreement with Mr. Kroger which memorializes the terms of salary deferral, only an election to do so, it is possible that he could demand payment in full at any time, elect to no longer defer his salary, or reduce the amount he currently defers.
Mr. Sandler, who has served as our principal financial and accounting officer since April 2010 and Vice President and Chief Administrative Officer since January 2000, is not a party to an employment agreement with the Company. His compensation is determined by Board of Directors. During 2017 and 2016 Mr. Sandler’s compensation package included a base annual salary of $112,000, with approximately $62,000 and $32,000, or 55% and 29% deferred in 2017 and 2016, respectively, and company-provided benefits and reimbursement of his health care premiums in the same percentage amount as provided to all employees. As there is no written agreement with Mr. Sandler which memorializes the terms of salary deferral, only an election to do so, it is possible that he could demand payment in full at any time, elect to no longer defer his salary, or reduce the amount he currently defers. The amount payable to Mr. Sandler can be increased at any time upon the determination of the Board and/or senior management.
18
Outstanding Equity Awards at Fiscal Year End
The following table provides information concerning unexercised options, stock that has not vested and equity incentive plan awards for each named executive officer outstanding as of December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPTION AWARDS
|
|
STOCK AWARDS
|
|
Name
|
|
Number of securities underlying unexercised options
(#)
exercisable
|
|
Number of securities underlying unexercised options
(#)
unexercisable
|
|
Equity incentive plan awards: Number of securities underlying unexercised unearned options
(#)
|
|
Option exercise price
($)
|
|
Option expiration date
|
|
Number of shares or units of stock that have not vested
(#)
|
|
Market value of shares or units of stock that have not vested
($)
|
|
Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested
(#)
|
|
Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested
(#)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph V. Vittoria
|
|
500,000
|
|
—
|
|
—
|
|
0.18
|
|
11/22/18
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Kevin Kroger
|
|
100,000
|
|
—
|
|
—
|
|
0.26
|
|
06/10/18
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
100,000
|
|
—
|
|
—
|
|
0.21
|
|
9/8/20
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
150,000
|
|
—
|
|
—
|
|
0.28
|
|
02/04/21
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
150,000
|
|
|
|
—
|
|
0.14
|
|
3/30/22
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
66,668
|
|
33,332
|
|
—
|
|
0.16
|
|
5/26/25
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Alan Sandler
|
|
100,000
|
|
—
|
|
—
|
|
0.26
|
|
06/10/18
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
100,000
|
|
—
|
|
—
|
|
0.30
|
|
08/05/18
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
75,000
|
|
—
|
|
—
|
|
0.21
|
|
09/08/20
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
75,000
|
|
—
|
|
—
|
|
0.28
|
|
02/04/21
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
75,000
|
|
—
|
|
—
|
|
0.14
|
|
3/30/22
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
66,668
|
|
33,332
|
|
—
|
|
0.16
|
|
5/26/25
|
|
—
|
|
—
|
|
—
|
|
—
|
Incentive and Non-qualified Stock Option and Stock Award Plans
We currently have two stock option plans, our 2010 Option Plan and our Directors' Plan. Our earlier plans which were adopted in 1996 and 1999 have expired by their terms. Please see Note 14 to the notes to our financial statements appearing elsewhere in this report for a description of the material terms of these plans.
Director Compensation
Each independent member of the Board of Directors is automatically granted 5,000 options upon election or appointment as a new member of the Board of Directors. Each independent director receives an additional 5,000 options at the close of each annual meeting of stockholders or on the anniversary of their appointment to the Board. Additionally, and at such time as the Board forms committees, each independent director automatically received 2,500 options for each committee of the Board on which the director serves. Options are granted at a price equal to the fair market value of the stock on the date of grant, are exercisable commencing two years following grant, and will expire five years from the date of grant. In the event a person ceases to serve on the Board of Directors, the outstanding options expire one year from the date of cessation of service. Our management directors do not receive any compensation for their services as directors.
The following table provides information concerning the compensation of our Board members for their services as members of our Board of Directors for 2017. The value attributable to any option awards is computed in accordance with FASB ASC Topic 718. The assumptions made in the valuations of the option awards are included in Note 14 of the Notes to our Financial Statements for the year ended December 31, 2017 appearing elsewhere in this report.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director Compensation
|
|
Name
|
|
Fees
earned or
paid in
cash
($)
|
|
Stock
awards
($)
|
|
Option
awards
($)
|
|
Non-equity
Incentive
Plan
Compensation
($)
|
|
Nonqualified
Deferred
Compensation
earnings
($)
|
|
All other
compensation
($)
|
|
Total
($)
|
|
Joseph V. Vittoria
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
John S. Caldwell
(1)
|
|
—
|
|
—
|
|
895
|
|
—
|
|
—
|
|
—
|
|
895
|
|
Kevin G. Kroger
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Dominick Telesco
(2)
|
|
24,000
|
|
—
|
|
330
|
|
—
|
|
—
|
|
—
|
|
24,330
|
———————
(1)
On August 25, 2017, General Caldwell was granted options to purchase 5,000 shares of common stock at an exercise price of $0.03 per share, vesting on August 25, 2019 and expiring on August 25, 2022.
19
(2)
If not previously exercised, Mr. Telesco’s options will expire one year following the date of his June 1, 2017 resignation from the board. On October 20, 2009, the Company entered into a consulting agreement with Boxwood Associates, Inc., whereby the Company pays $2,000 monthly for management and strategic development services performed. The contract will remain in effect until terminated by either party providing 30 days written notice. Mr. Telesco is President of Boxwood Associates, Inc.
ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
At March 27, 2018 we had 69,016,468 shares of our common stock issued and outstanding. The following table sets forth information regarding the beneficial ownership of our common stock as of March 27, 2018 by:
·
each person known by us to be the beneficial owner of more than 5% of our common stock;
·
each of our directors;
·
each of our named executive officers; and
·
our named executive officers, directors and director nominees as a group.
Unless otherwise indicated, the business address of each person listed is in care of 2017 High Ridge Road, Boynton Beach, Florida 33426. The percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our common stock outstanding on that date and all shares of our common stock issuable to that holder in the event of exercise of outstanding options, warrants, rights or conversion privileges owned by that person at that date which are exercisable within 60 days of that date. Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our common stock owned by them, except to the extent that power may be shared with a spouse.
|
|
|
|
|
|
NAME OF BENEFICIAL OWNER
|
|
AMOUNT AND NATURE
OF BENEFICIAL OWNERSHIP
|
|
% OF CLASS
|
|
Joseph V. Vittoria
(1)
|
|
26,097,753
|
|
37.8%
|
|
Kevin G. Kroger
(2)
|
|
1,226,041
|
|
1.8%
|
|
Alan J. Sandler
(3)
|
|
513,270
|
|
*
|
|
Lieutenant General John S. Caldwell, Jr. US Army (retired)
(4)
|
|
22,500
|
|
*
|
|
All officers and directors as a group (five persons)
(1)(2)(3)(4)
|
|
27,857,064
|
|
39.6%
|
|
Dominick Telesco
(5)
|
|
6,237,570
|
|
9.0%
|
———————
*
represents less than 1%
(1)
The number of shares beneficially owned by Mr. Vittoria includes:
·
options to purchase 500,000 shares of common stock at $0.18 per share through November 22, 2018.
(2)
The number of shares beneficially owned by Mr. Kroger includes:
·
options to purchase 100,000 shares of common stock at $0.26 per share through June 10, 2018;
·
options to purchase 100,000 shares of our common stock at an exercise price of $0.21 per share through September 8, 2020;
·
options to purchase 150,000 shares of our common stock at an exercise price of $0.28 per share through February 4, 2021;
·
options to purchase 150,000 shares of our common stock at an exercise price of $0.14 per share through March 30, 2022; and
·
options to purchase 66,668 shares of our common stock at an exercise price of $0.16 per share through May 26, 2025.
The number of shares beneficially owned by Mr. Kroger excludes:
·
unvested options to purchase 33,332 shares of common stock at $0.16 per share through May 26, 2025.
(3)
The number of shares beneficially owned by Mr. Sandler includes:
·
options to purchase 100,000 shares of common stock at $0.26 per share through June 10, 2018;
·
options to purchase 100,000 shares of common stock at $0.30 per share through August 5, 2018;
·
options to purchase 75,000 shares of our common stock at an exercise price of $0.21 per share through September 8, 2020;
20
·
options to purchase 75,000 shares of our common stock at an exercise price of $0.28 per share through February 4, 2021;
·
options to purchase 75,000 shares of our common stock at an exercise price of $0.14 per share through March 30, 2022; and
·
options to purchase 66,668 shares of our common stock at an exercise price of $0.16 per share through May 26, 2025.
The number of shares beneficially owned by Mr. Sandler excludes:
·
unvested option to purchase 33,332 shares of common stock at $0.16 per share through May 26, 2025.
(4)
The number of shares beneficially owned by General Caldwell includes:
·
options to purchase 7,500 shares of common stock at $0.18 per share through August 25, 2018;
·
options to purchase 7,500 shares of common stock at $0.27 per share through August 25, 2019; and
·
options to purchase 7,500 shares of common stock at $0.13 per share through August 25, 2020.
The number of shares beneficially owned by General Caldwell excludes:
·
unvested options to purchase 5,000 shares of common stock at $0.04 per share through August 25, 2021; and
·
unvested options to purchase 5,000 shares of common stock at $0.034 per share through August 25, 2022.
(5)
The number of shares beneficially owned by Mr. Telesco includes:
·
options to purchase 5,000 shares of common stock at $0.15 per share through June 1, 2018; and
·
options to purchase 5,000 shares of common stock at $0.22 per share through June 1, 2018.
Securities Authorized for Issuance under Equity Compensation Plans
The following table sets forth securities authorized for issuance under any equity compensation plans approved by our stockholders as well as any equity compensation plans not approved by our stockholders as of December 31, 2017.
|
|
|
|
|
|
|
|
|
|
Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights
(a)
|
|
Weighted average
exercise price of
outstanding options,
warrants and rights
(b)
|
|
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column
(a) (c)
|
|
Plan category
|
|
|
|
|
|
|
|
Plans approved by stockholders:
|
|
|
|
|
|
|
|
1999 Stock Option Plan
|
|
992,008
|
|
.35
|
|
—
|
|
2010 Stock Option Plan
|
|
2,418,057
|
|
.20
|
|
1,430,279
|
|
2000 Non-Employee Directors Plan
|
|
150,000
|
|
.20
|
|
245,000
|
|
Plans not approved by stockholders
|
|
N/A
|
|
N/A
|
|
N/A
|
ITEM 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTION, AND DIRECTOR INDEPENDENCE.
Please see Note 16 to the Company's audited financial statements appearing elsewhere in this report for a description of transactions with related parties during 2017 and 2016.
Director Independence
John S. Caldwell is considered "independent” within the meaning of Rule 5605 of the NASDAQ Marketplace Rules.
21
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2017 AND 2016
1. Significant Accounting Policies
Organization
Puradyn Filter Technologies Incorporated (the “Company”), a Delaware corporation, is engaged in the manufacturing, distribution and sale of bypass oil filtration systems under the trademark Puradyn
®
primarily to companies within targeted industries. The Company holds the exclusive worldwide manufacturing and marketing rights for the Puradyn through direct ownership of various other patents.
Revenue Recognition
The Company recognizes revenue from product sales to customers, distributors and resellers when products that do not require further services or installation by the Company are shipped, when there are no uncertainties surrounding customer acceptance and when collectability is reasonably assured in accordance with FASB ASC 605,
Revenue Recognition
, as amended and interpreted. Cash received by the Company prior to shipment is recorded as deferred revenue. Sales are made to customers under terms allowing certain limited rights of return and other limited product and performance warranties for which provision has been made in the accompanying financial statements.
Amounts billed to customers in sales transactions related to shipping and handling, represent revenues earned for the goods provided and are included in net sales. Costs of shipping and handling are included in cost of products sold.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about allowances for inventory obsolescence, useful life of fixed assets, warranty reserves and bad-debt reserves, valuation allowance on the deferred tax asset, life of intangible assets, impairment of intangible assets and the assumptions used in Black-Scholes valuation models related to stock options and warrants.
Cash and Cash Equivalents
Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At December 31, 2017 and December 31, 2016, the Company did not have any cash equivalents.
Fair Value of Financial Instruments
The carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and notes payable to stockholder approximate their fair values as of December 31, 2017 and December 31, 2016, respectively, because of their short-term natures.
Accounts Receivable
Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.
F-6
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.
Inventories
Inventories are stated at the lower of cost or market using the first in, first out (FIFO) method. Production costs, consisting of labor and overhead, are applied to ending finished goods inventories at a rate based on estimated production capacity. Excess production costs are charged to cost of products sold. Provisions have been made to reduce excess or obsolete inventories to their net realizable value.
Property and Equipment
Property and equipment are stated at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the related assets, except for assets held under capital leases, for which the Company records depreciation and amortization based on the shorter of the asset’s useful life or the term of the lease. The estimated useful lives of property and equipment range from 3 to 5 years. Upon sale or retirement, the cost and related accumulated depreciation and amortization are eliminated from their respective accounts, and the resulting gain or loss is included in results of operations. Repairs and maintenance charges, which do not increase the useful lives of the assets, are charged to operations as incurred.
Patents
Patents are stated at cost. Amortization is provided using the straight-line method over the estimated useful lives of the patents. The estimated useful lives of patents are approximately 20 years. Upon retirement, the cost and related accumulated amortization are eliminated from their respective accounts, and the resulting gain or loss is included in results of operations.
Impairment of Long-Lived Assets
Management assesses the recoverability of its long-lived assets when indicators of impairment are present. If such indicators are present, recoverability of these assets is determined by comparing the undiscounted net cash flows estimated to result from those assets over the remaining life to the assets’ net carrying amounts. If the estimated undiscounted net cash flows are less than the net carrying amount, the assets would be adjusted to their fair value, based on appraisal or the present value of the undiscounted net cash flows.
Sales Incentives and Consideration Paid to Customers
The Company accounts for certain promotional costs such as sales incentives and cooperative advertising as a reduction of sales.
Product Warranty Costs
As required by FASB ASC 460,
Guarantees
, the Company is including the following disclosure applicable to its product warranties.
The Company accrues for warranty costs based on the expected material and labor costs to provide warranty replacement products. The methodology used in determining the liability for warranty cost is based upon historical information and experience. The Company's warranty reserve is calculated as the gross sales multiplied by the historical warranty expense return rate.
F-7
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
The following table shows the changes in the aggregate product warranty liability for the year ended December 31, 2017 and December 31, 2016, respectively:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
Balance as of beginning of year
|
|
$
|
20,000
|
|
$
|
20,000
|
|
|
Less: Payments made
|
|
|
—
|
|
|
—
|
|
|
Add: Provision for current years warranty
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of end of year
|
|
$
|
20,000
|
|
$
|
20,000
|
|
Advertising Costs
Advertising costs are expensed as incurred. During the years ended December 31, 2017 and 2016, advertising costs incurred by the Company totaled approximately $1,251 and $12,130, respectively, and are included in selling and administrative expenses in the accompanying statements of operations.
Engineering and Development
Engineering and development costs are expensed as incurred. During the years ended December 31, 2017 and 2016, engineering and development costs incurred by the Company totaled $6,981 and $9,068, respectively, and are included in selling and administrative expenses in the accompanying statements of operations.
Income Taxes
The Company accounts for income taxes under FASB ASC 740,
Income Taxes
. Deferred income tax assets and liabilities are determined based upon differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Stock Option Plans
We adopted FASB ASC 718,
Compensation-Stock Compensation,
effective January 1, 2006 using the modified prospective application method of adoption which requires us to record compensation cost related to unvested stock awards as of December 31, 2005 by recognizing the amortized grant date fair value in accordance with provisions of FASB ASC 718 on straight line basis over the service periods of each award. We have estimated forfeiture rates based on our historical experience. Stock option compensation expense for the year ended December 31, 2017 has been recognized as a component of cost of goods sold and general and administrative expenses in the accompanying financial statements.
In 2017 and 2016, respectively, 5,000 and 30,000 options were granted at fair market value on the date of grant pursuant to the Stock Option Plan.
The Company leases its employees from a payroll leasing company. The Company’s leased employees meet the definition of employees as specified by FIN 44 for purposes of applying FASB ASC 718.
Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable in accordance with
FASB ASC 505,
Equity,
and FASB ASC 718
, Compensation-Stock Compensation,
including related amendments and interpretations. The related expense is recognized over the period the services are provided.
F-8
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
Credit Risk
The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the FDIC insured limit of $250,000 are at risk. At December 31, 2017 and December 31, 2016, respectively, the Company did not have cash balances above the FDIC insured limit. The Company performs ongoing evaluations of its significant trade accounts receivable customers and generally does not require collateral. An allowance for doubtful accounts is maintained against trade accounts receivable at levels which management believes is sufficient to cover probable credit losses. The Company also has some customer concentrations, and the loss of business from one or a combination of these significant customers, or an unexpected deterioration in their financial condition, could adversely affect the Company’s operations. Please refer to Note 18 for further details.
Basic and Diluted Loss Per Share
FASB ASC 260,
Earnings per Share
, requires a dual presentation of basic and diluted earnings per share. However, because of the Company’s net losses, the effects of stock options and warrants would be anti-dilutive and, accordingly, are excluded from the computation of earnings per share. The number of such shares excluded from the computations of diluted loss per share totaled 4,170,162 in 2017 and 4,680,840 in 2016.
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements
In August 2015, FASB issued ASU No. 2015-14, “
Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date
” defers the effective date ASU No. 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2018, and interim reporting periods within annual reporting periods beginning after December 15, 2019. All other entities may apply the guidance in ASU No. 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, including interim reporting periods within that reporting period. All other entities also may apply the guidance in Update 2014-09 earlier as of an annual reporting period beginning after December 15, 2016, and interim reporting periods within annual reporting periods beginning one year after the annual reporting period in which the entity first applies the guidance in ASU No. 2014-09. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.
In August 2016, the FASB issued ASU 2016-15, "
Classification of Certain Cash Receipts and Cash Payments
," which aims to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. ASU 2016-15 is effective for annual reporting periods, and interim periods therein, beginning after December 15, 2017. The Company has not yet determined the potential effects of the adoption of ASU 2016-15 on its financial statements. In March 2016, the FASB issued ASU No. 2016-09, “
Compensation – Stock Compensation (Topic 718)
” (“ASU 2016-09”). This guidance which simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. This guidance is effective for annual periods beginning after December 15, 2016, including interim periods within those annual reporting periods. Early adoption is permitted. We are currently evaluating the full impact of the new standard.
F-9
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
In February 2016, the FASB issued ASU 2016-02,
Leases
, which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.
All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.
2. Going Concern
The Company’s financial statements have been prepared on the basis that it will operate as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net losses each year since inception, negative cash flows, and has relied on loans from its principal shareholder to fund its operations. The principal stockholder has recently advised the Company that he does not expect to continue to provide working capital advances to the Company at historic levels. If the Company does not raise funds as needed, or if the principal stockholder should discontinue his practice of advancing funds, the Company’s existing business and operations will be in jeopardy.
These recurring operating losses, liabilities exceeding assets and the reliance on cash inflows from a current stockholder have led the Company’s management to conclude there is substantial doubt about the Company’s ability to continue as a going concern.
3. Inventories
At December 31, 2017 and December 31, 2016 inventories consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
Raw materials
|
|
$
|
901,600
|
|
$
|
1,074,156
|
|
|
Finished goods
|
|
|
125,932
|
|
|
112,535
|
|
|
Work in process
|
|
|
16,848
|
|
|
—
|
|
|
Valuation allowance
|
|
|
(643,616
|
)
|
|
(504,583
|
)
|
|
|
|
$
|
400,764
|
|
$
|
682,108
|
|
4. Prepaid Expenses and Other Current Assets
At December 31, 2017 and December 31, 2016, prepaid expenses and other current assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
$
|
26,648
|
|
$
|
27,447
|
|
|
Deposits
|
|
|
42,707
|
|
|
28,000
|
|
|
|
|
$
|
69,355
|
|
$
|
55,447
|
|
F-10
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
5. Property and Equipment
At December 31, 2017 and December 31, 2016, property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
Machinery and equipment
|
|
$
|
1,045,217
|
|
$
|
1,045,217
|
|
|
Furniture and fixtures
|
|
|
56,558
|
|
|
56,558
|
|
|
Leasehold improvements
|
|
|
152,322
|
|
|
129,722
|
|
|
Software and website development
|
|
|
88,842
|
|
|
88,842
|
|
|
Computer hardware and software
|
|
|
153,249
|
|
|
153,249
|
|
|
|
|
|
1,496,188
|
|
|
1,473,588
|
|
|
Less accumulated depreciation and amortization
|
|
|
(1,450,861
|
)
|
|
(1,431,086
|
)
|
|
|
|
$
|
45,327
|
|
$
|
42,502
|
|
Depreciation and amortization expense of property and equipment for the years ended December 31, 2017 and 2016 is $19,775 and $22,579, respectively, of which $4,529 and $5,064 is included in cost of products sold, and $15,246 and $17,533 is included in selling and administrative costs, respectively, in the accompanying statements of operations. During the year ended December 31, 2017 the Company recognized a loss of $1,808 on the disposal of fixed assets.
6. Patents
Included in other assets at December 31, 2017 and 2016 are capitalized patent costs as follows:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
Patent costs
|
|
$
|
558,873
|
|
$
|
482,142
|
|
|
Less accumulated amortization
|
|
|
(62,153
|
)
|
|
(47,555
|
)
|
|
|
|
$
|
496,720
|
|
$
|
434,587
|
|
Amortization expense for the year ended December 31, 2017 and 2016 amounted to $14,598 and $14,043, respectively.
7. Leases
The Company leases its office and warehouse facilities in Boynton Beach, Florida under a long-term non-cancellable lease agreement, which contains renewal options and rent escalation clauses. As of December 31, 2014, a security deposit of $34,970 is included in noncurrent assets in the accompanying balance sheet. During 2008, this lease was renewed effective August 1,
2008 and expired on July 31, 2013 and contained an annual increase of 3%. During June 2009, an amendment to the lease agreement was reached, temporarily reducing the monthly rent. The total minimum lease payments over the term of the lease were reduced from an aggregate of approximately $956,000 to approximately $925,000, or approximately 3%. On September 27, 2012 the Company entered into a non-cancellable lease agreement for the same facilities commencing August 1, 2013 and expiring July 31, 2019. The total minimum lease payments over the term of the lease signed on September 27, 2012 amount to $909,383. See Note 11.
The Company leased a condominium in Ocean Ridge, Florida, on an annual basis, to provide accommodations for Company use, primarily for Mr. Alan Sandler and Mr. Kevin Kroger, the Company’s Principal Financial Officer, Vice President and Chief Administrative Officer, and Chief Operating Officer, respectively. The lease has an annual expense of $8,500. In December 2017, the Company did not renew the lease.
Rent expense under all operating leases for the years ended December 31, 2017 and 2016 totaled $280,880 and $268,759, respectively, of which $212,454 and $204,568 is included in cost of products sold and $66,346 and $64,191 is included in selling and administrative costs, respectively, in the accompanying statements of operations.
F-11
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
In January 2012 and August 2011, the Company entered into capital lease obligations for the purchase of $15,383 and $13,681, respectively of office equipment, which is included in property and equipment. As of December 31, 2017 and 2016 the office equipment was recorded net of $6,008 and $7,198 respectively, of accumulated depreciation, in the accompanying balance sheets. In January 2015 the Company entered into a new capital lease for office equipment in the amount of $15,020.
Future minimum lease commitments due for facilities and equipment leases under non-cancellable capital and operating leases at December 31, 2017 are as follows:
|
|
|
|
|
|
|
|
|
|
|
Capital Leases
|
|
Operating Leases
|
|
|
2018
|
|
$
|
3,443
|
|
$
|
164,448
|
|
|
2019
|
|
|
—
|
|
|
97,586
|
|
|
Total minimum lease payments
|
|
|
3,443
|
|
$
|
262,034
|
|
|
Less amount representing interest
|
|
|
—
|
|
|
|
|
|
Present value of minimum lease payments
|
|
$
|
3,443
|
|
|
|
|
8. Accrued Liabilities
At December 31, 2017 and December 31, 2016, accrued liabilities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
Accrued wages and benefits
|
|
$
|
69,025
|
|
$
|
60,904
|
|
|
Accrued expenses relating to vendors and others
|
|
|
136,681
|
|
|
138,863
|
|
|
Accrued warranty costs
|
|
|
20,000
|
|
|
20,000
|
|
|
Accrued interest payable relating to stockholder notes
|
|
|
115,039
|
|
|
84,988
|
|
|
Deferred rent
|
|
|
22,059
|
|
|
30,155
|
|
|
|
|
$
|
362,804
|
|
$
|
334,910
|
|
9. Deferred Compensation
Deferred compensation represents amounts owed to three employees for salary. As there is no written agreement with these employees which memorializes the terms of salary deferral, only a voluntary election to do so, it is possible that the employees could demand payment in full at any time. As of December 31, 2017 and 2016 the Company recorded deferred compensation of $1,626,003 and $1,602,826, respectively.
10.
Sales Incentives
On September 7, 2017, the Company entered into an exclusive distribution agreement for the worldwide rights to sell its product in the oil and gas industry effective September 7, 2017. An incentive program will be used to compensate the distributor for the difference between the price of product currently being charged by PFTI offered to the distributor for the oil and gas industry and the applicable distributor price currently available. The incentive, in the form of credits toward future product, is redeemable only if targeted quarterly goals are achieved. If the goals are not achieved the credits will be carried forward and are redeemable when the quarterly goals are achieved. As of December 31, 2017, the Company recorded a credit toward future product of $99,128.
Targeted quarterly goals, if achieved, represent an aggregate of approximately $4 million in sales revenue between August 1, 2017 and June 30, 2018. Sales under the agreement amount to $558,141 for the period from August 1, 2017 to December 31, 2017.
F-12
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
11. Notes Payable to Stockholders and Capital Leases
Beginning on March 28, 2002 the Company executed a binding agreement with one of its principal stockholders, who is also the Chairman of the Board and an Executive officer, to fund up to $6.1 million. Under the terms of the agreements, the Company can draw amounts as needed to fund operations. Amounts drawn bear interest at the BBA LIBOR Daily Floating Rate plus 1.4 percentage points (3.62% and 2.5865% per annum at December 31, 2017 and 2016, respectively), payable monthly and were to become due and payable on December 31, 2005 or upon a change in control of the Company or consummation of any other financing over $7.0 million. Beginning in March 2006, annually, through February 2012, the maturity date for the agreement was extended annually from December 31, 2007, to December 31, 2017. On November 16, 2017, our Chairman and Chief Executive Officer extended the due date of the funding commitment to December 31, 2018. Refer to Note 17.
During the year ended December 31, 2017 we borrowed an additional $875,000 from him and repaid $0, and at December 31, 2017 we owed him $7,963,349 which represented approximately 78% of our total liabilities. Subsequent to December 31, 2017, he has advanced an additional $200,000 in working capital funding. On November 11, 2016 $6.1 million of principal and interest was converted into 20,333,333 shares of our common stock at a conversion price of $0.30 per share. This conversion was above the market price of our common stock. The balance of this loan, which is unsecured, matures on December 31, 2018. While he has continued to fund our working capital needs at reduced levels and extend the due date of the obligation for an additional year, he is under no contractual obligation to do so. During 2017 he advised us he does not expect to continue to provide working capital advances to us at historic amounts. If we are unable to meet our obligation to our Chairman and Chief Executive Officer prior to maturity, he has advised us that he may forgive all, or substantially all, of this obligation.
Additionally, the Company had unsecured loans outstanding from a former member of the board of directors who is also a significant stockholder, totaling $100,000 at December 31, 2016. The notes bear interest at a rate of 5% per annum and are due upon demand. During the year ended December 31, 2017, we repaid him $50,000 and in addition, he forgave $50,000 and accrued interest of $2,664. The forgiveness was treated as a capital contribution. In November 2017, the Company received an additional loan in the amount of $25,000 from this same former member of the Board of Directors. The loan bears interest at a rate of 5% per annum and is due December 31, 2018. Refer to Note 17.
During the years ended December 31, 2017 and 2016, the Company incurred interest expense of $271,311 and $345,734, respectively, on its loans from this stockholder, which is included in interest expense in the accompanying statements of operations. Also included in interest expense at December 31, 2017 and 2016 were $2,205 and $980 of interest related to capital lease obligations, financing, late fees and loans from a stockholder.
Notes payable and capital leases consisted of the following at December 31, 2017 and December 31, 2016:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
Notes payable to stockholders
|
|
$
|
7,988,349
|
|
$
|
7,188,349
|
|
|
Capital lease obligation
|
|
|
3,443
|
|
|
7,198
|
|
|
|
|
|
7,991,792
|
|
|
7,195,547
|
|
|
Less: current maturities
|
|
|
(7,991,792
|
)
|
|
(3,443
|
)
|
|
|
|
$
|
—
|
|
$
|
7,192,140
|
|
Maturities of Long-Term Obligations for Five Years and Beyond
The minimum annual principal payments of notes payable and capital lease obligations at December 31, 2017 were:
|
|
|
|
|
|
2018
|
|
$
|
7,991,792
|
|
|
|
|
$
|
7,991,792
|
|
F-13
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
12. Income Taxes
2017 U.S. Tax Reform
On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the “TCJA”) that significantly reforms the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). The TCJA, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January 1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December 31, 2017 (though any such tax losses may be carried forward indefinitely); modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as “orphan drugs”; and repeal of the federal Alternative Minimum Tax (“AMT”).
The staff of the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the TCJA. In connection with the initial analysis of the impact of the TCJA, the Company remeasured its deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. The remeasurement of the Company's deferred tax assets and liabilities was offset by a change in the valuation allowance.
The Company is still in the process of analyzing the impact to the Company of the TCJA. Where the Company has been able to make reasonable estimates of the effects related to which its analysis is not yet complete, the Company has recorded provisional amounts. The ultimate impact to the Company’s consolidated financial statements of the TCJA may differ from the provisional amounts due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the TCJA. The accounting is expected to be complete when the Company’s 2017 U.S. corporate income tax return is filed in 2018.
The significant components of the Company’s net deferred tax assets are as follows for the years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
12,207,686
|
|
$
|
16,432,788
|
|
|
Accrued expenses and reserves
|
|
|
172,212
|
|
|
203,045
|
|
|
Compensatory stock options and warrants
|
|
|
165,946
|
|
|
228,672
|
|
|
Other
|
|
|
1,252
|
|
|
5,407
|
|
|
Total deferred tax assets
|
|
|
12,547,096
|
|
|
16,869,912
|
|
|
Valuation allowance
|
|
|
(12,547,096
|
)
|
|
(16,869,912
|
)
|
|
Net deferred tax assets
|
|
$
|
—
|
|
$
|
—
|
|
FASB ASC 740,
Income Taxes,
requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a full valuation allowance of $12,547,096 and $16,869,912 against its net deferred taxes is necessary as of December 31, 2017 and December 31, 2016, respectively. The change in valuation allowance for the years ended December 31, 2017 and 2016 is $4,322,819 and $446,892 respectively.
At December 31, 2017 and December 31, 2016, respectively, the Company had $48,166,052 and $43,669,900, respectively, of U.S. net operating loss carryforwards remaining.
As a result of certain ownership changes, the Company may be subject to an annual limitation on the utilization of its U.S. net operating loss carryforwards pursuant to Section 382 of the Internal Revenue Code. A study to determine the effect, if any, of this change, has not been undertaken.
F-14
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
Tax returns for the years ended December 31, 2017, 2016, 2015, 2014, and 2013 are subject to examination by the Internal Revenue Service.
A reconciliation of the Company’s income taxes to amounts calculated at the federal statutory rate is as follows for the years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
Federal statutory taxes
|
|
|
(34.00
|
)%
|
|
|
(34.00
|
)%
|
|
|
State income taxes, net of federal tax benefit
|
|
|
(3.63
|
)
|
|
|
(3.63
|
)
|
|
|
Nondeductible items
|
|
|
0.00
|
|
|
|
0.72
|
|
|
|
Change in tax rate estimates
|
|
|
389.49
|
|
|
|
—
|
|
|
|
Change in valuation allowance
|
|
|
(351.86
|
)
|
|
|
36.91
|
|
|
|
|
|
|
—
|
%
|
|
|
—
|
%
|
|
13. Commitments and Contingencies
Agreements
On September 7, 2017 the Company entered into an exclusive distribution agreement for the worldwide rights to sell its product in the oil and gas industry. The distributor will receive sales incentive credits toward future product, based upon the difference in current pricing and new pricing detailed in the agreement. The credits toward future product are only redeemable if targeted quarterly goals are achieved. If the goals are not achieved the credits will be carried forward and are redeemable when the quarterly goals are achieved. Refer to Note 10.
On March 7, 2016, the Company entered into an Advisory Agreement for duration of six months with an outside consultant, who is also a stockholder. We issued the consultant five year warrants to purchase 350,000 shares of the Company's common stock with an exercise price of $0.05 per share.
On September 27, 2012, the Company entered into a 72 month lease for its corporate offices and warehouse facility in Boynton Beach, Florida. The renewed lease commences August 1, 2013 and requires an initial rent of $12,026 per month beginning in the second month for the first year, increasing in varying amounts to $13,941 per month in the sixth year. In addition, the Company is responsible for all operating expenses and utilities.
On October 20, 2009, the Company entered into a consulting agreement with Boxwood Associates, Inc., whereby the Company pays $2,000 monthly for management and strategic development services performed. The contract will remain in effect until terminated by either party providing 30 days written notice. Mr. Telesco, is a former member of our board of directors, and a significant stockholder, is President of Boxwood Associates, Inc. Refer to Note 17.
14. Stock Options
The Company has three stock option plans, one adopted in September 1999 and amended in June 2000 (the “1999 Option Plan”, which expired in 2009), one adopted on November 8, 2000 (the “Directors’ Plan”), and one adopted in July 2010 (the “2010 Option Plan”). The 1999 Option Plan provided for the granting of up to 3,000,000 options, the Directors’ Plan provides for the granting of up to 400,000 options, and the 2010 Option Plan provides for the granting of 4,000,000 options.
On June 24, 2014, the Company filed a registration statement on Form S-8 with the Securities and Exchange Commission amending the shares of Common Stock included within its 2010 Stock Option from 2,000,000 shares to 4,000,000 shares.
F-15
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
The 2010 Plan provides for the granting of both incentive and non-qualified stock options to key personnel, including officers, directors, consultants and advisors to the Company, at the discretion of the Board of Directors. Each plan limits the exercise price of the options at no less than the quoted market price of the common stock on the date of grant. The option term is determined by the Board of the Directors, provided that no option may be exercisable more than 10 years after the date of its grant and, in the case of an Incentive Option granted to an eligible employee owning more than 10% of the Company’s common stock, no more than five years after the date of the grant. Generally, under both plans, options to employees vest over four years at 25% per annum, except for certain grants to employees that vest 25% upon grant with remaining amounts over two years at 50% and 25% per annum, respectively.
The Directors’ Plan provides for the granting of non-qualified options to members of the Board of Directors at exercise prices not less than the quoted market price of the common stock on the date of grant and options expire five years from the date of grant. In the event a person ceases to serve on the Board of Directors, the outstanding options expire one year from the date of cessation of service. Such options may be exercised commencing two years from the date of grant.
On August 25, 2017, the Company granted one director options to purchase 5,000 shares of the Company’s common stock, at an exercise price of $0.03 per share. The options vest over a two year period and expire August 25, 2022. The quoted market price of the common stock at the time of issuance of the options was $0.03 per share. The fair value of the options totaled $167 using the Black-Scholes option pricing model with the following assumptions: i) risk free interest rate of 1.54%, ii) expected life of 5 years, iii) dividend yield of 0%, iv) expected volatility of 210%.
On April 5, 2016, the Company granted an employee options to purchase 20,000 shares of the Company’s common stock, at an exercise price of $0.04 per share. The options vest over a four-year period and expire April 5, 2026. The quoted market price of the common stock at the time of issuance of the options was $0.04 per share. The fair value of the options totaled $696 using the Black-Scholes option pricing model with the following assumptions: i) risk free interest rate of 1.38%, ii) expected life of 10 years, iii) dividend yield of 0%, iv) expected volatility of 172%.
On August 25, 2016, the Company granted one director options to purchase 5,000 shares of the Company’s common stock, at an exercise price of $0.04 per share. The options vest over a two year period and expire August 25, 2021. The quoted market price of the common stock at the time of issuance of the options was $0.04 per share. The fair value of the options totaled $169 using the Black-Scholes option pricing model with the following assumptions: i) risk free interest rate of .8%, ii) expected life of 5 years, iii) dividend yield of 0%, iv) expected volatility of 188%.
On December 19, 2016, the Company granted one director options to purchase 5,000 shares of the Company’s common stock, at an exercise price of $0.07 per share. The options vest over a two year period and expire December 19, 2021. The quoted market price of the common stock at the time of issuance of the options was $0.07 per share. The fair value of the options totaled $343 using the Black-Scholes option pricing model with the following assumptions: i) risk free interest rate of 1.45%, ii) expected life of 5 years, iii) dividend yield of 0%, iv) expected volatility of 207%.
At December 31, 2017 there was $10,450 of unrecognized compensation cost related to nonvested share-based payments, which is expected to be recognized over a weighted-average period of 4 years. At December 31, 2016 there was $59,168 of unrecognized compensation cost related to nonvested share-based payments, which is expected to be recognized over a weighted-average period of 4 years.
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for those awards that have an exercise price currently below the closing price. As of December 31, 2017 and 2016, the Company had options outstanding to purchase an aggregate of 3,180,000 and 3,365,500 shares respectively, with an exercise price above the quoted price of the Company’s stock, resulting in no intrinsic value.
F-16
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
Additional information concerning the activity in the three option plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
|
Outstanding, beginning of year
|
|
|
3,365,500
|
|
$
|
0.20
|
|
|
3,858,000
|
|
$
|
0.22
|
|
|
Granted
|
|
|
5,000
|
|
|
0.03
|
|
|
30,000
|
|
|
0.05
|
|
|
Exercised
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Forfeited
|
|
|
(36,667
|
)
|
|
(0.14
|
|
|
—
|
|
|
—
|
|
|
Expired
|
|
|
(153,833
|
)
|
|
(0.22
|
)
|
|
(522,500
|
)
|
|
(0.30
|
)
|
|
Outstanding, end of year
|
|
|
3,180,000
|
|
$
|
0.20
|
|
|
3,365,500
|
|
$
|
0.20
|
|
|
Exercisable, end of year
|
|
|
2,909,160
|
|
$
|
0.20
|
|
|
2,804,660
|
|
$
|
0.20
|
|
|
Options available for future grant, end of year
|
|
|
1,245,500
|
|
|
|
|
|
1,303,336
|
|
|
|
|
Additional information concerning the unvested options is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
|
Non-Vested options at beginning of year
|
|
|
560,840
|
|
$
|
0.17
|
|
|
1,006,667
|
|
$
|
0.17
|
|
|
Granted
|
|
|
5,000
|
|
|
0.03
|
|
|
30,000
|
|
|
0.05
|
|
|
Vested
|
|
|
(258,333
|
)
|
|
(0.16
|
)
|
|
(445,827
|
)
|
|
(0.17
|
)
|
|
Forfeited
|
|
|
(36,667
|
)
|
|
(0.14
|
)
|
|
|
|
|
|
|
|
Cancelled
|
|
|
—
|
|
|
—
|
|
|
(30,000
|
)
|
|
(0.17
|
)
|
|
Non-Vested options end of year
|
|
|
270,840
|
|
$
|
0.15
|
|
|
560,840
|
|
$
|
0.16
|
|
Summarized information with respect to options outstanding under the three option plans at December 31, 2017 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
|
|
Range of
Exercise Price
|
|
Number
Outstanding
|
|
Remaining
Average
Contractual
Life (In Years)
|
|
Weighted
Average
Exercise Price
|
|
Number
Exercisable
|
|
Weighted
Average
Exercise Price
|
|
|
$0.026 - $0.35
|
|
3,180,000
|
|
3.63
|
|
$0.20
|
|
2,909,160
|
|
$0.20
|
|
The estimated fair value of each stock option grant on the date of grant was computed using the following weighted-average assumptions:
|
|
|
|
|
|
|
|
December 31,
|
|
|
2017
|
|
2016
|
|
Risk-free interest rate
|
1.54
|
%
|
|
0.79%-1.45
|
%
|
|
Expected term (life) of options (in years)
|
5
|
|
|
4-10
|
|
|
Expected dividends
|
—
|
|
|
—
|
|
|
Expected volatility
|
210
|
%
|
|
172%-206.
|
%
|
15. Common Stock
On November 11, 2016 $6.1 million of principal and interest was converted into 20,333,333 shares of our common stock at a conversion price of $0.30 per share. This conversion was above the market price of our common stock. The balance of this loan, which is unsecured, matures on December 31, 2018.
F-17
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
16. Warrants
At December 31, 2017 and 2016, 990,162 and 1,315,340 shares, respectively, of common stock have been reserved for issuance under outstanding warrants. All of the warrants are fully vested and began expiring on March 24, 2013 with the remaining warrants expiring at various dates through October 1, 2019. Information concerning the Company’s warrant activity is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
Warrants
|
|
Weighted
Average
Exercise
Price
|
|
Warrants
|
|
Weighted
Average
Exercise
Price
|
|
|
Outstanding, at the beginning of year
|
|
|
1,315,340
|
|
$
|
0.24
|
|
|
1,099,915
|
|
$
|
0.32
|
|
|
Granted
|
|
|
—
|
|
|
—
|
|
|
350,000
|
|
|
0.05
|
|
|
Exercised
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Expired
|
|
|
(325,178
|
)
|
|
(0.35
|
)
|
|
(134,575
|
)
|
|
(0.39
|
)
|
|
Outstanding, at the end of year
|
|
|
990,162
|
|
$
|
0.20
|
|
|
1,315,340
|
|
$
|
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants Outstanding – December 31, 2017
|
|
|
Range of
Exercise Price
|
|
|
Number
Outstanding
|
|
|
Remaining Average
Contractual Life
(In Years)
|
|
|
Weighted Average
Exercise Price
|
|
|
$0.05 -$0.35
|
|
|
|
990,162
|
|
|
|
1.92
|
|
|
|
$0.20
|
|
|
Totals
|
|
|
|
990,162
|
|
|
|
1.92
|
|
|
|
$0.20
|
|
On March 7, 2016, The Company granted warrants to purchase 350,000 shares of its common stock, priced at $0.05 per share. The warrants vest immediately and expire March 7, 2021. The quoted market price of the common stock at the time of issuance of the warrants was $0.09 per share. The fair value of the warrants totaled $30,277 using the Black-Scholes pricing model with the following assumptions: i) risk free interest rate of 0.99%, ii) expected life of 5 years, iii) dividend yield of 0%, iv) expected volatility of 171%.
17. Related Party Transactions
Beginning on March 28, 2002 the Company executed a binding agreement with one of its principal stockholders, who is also the Chairman of the Board and an Executive officer, to fund up to $6.1 million. Under the terms of the agreements, the Company can draw amounts as needed to fund operations. Amounts drawn bear interest at the BBA LIBOR Daily Floating Rate plus 1.4 percentage points (3.62% and 2.5865% per annum at December 31, 2017 and 2016, respectively), payable monthly and were to become due and payable on December 31, 2005 or upon a change in control of the Company or consummation of any other financing over $7.0 million. Beginning in March 2006, annually, through February 2012, the maturity date for the agreement was extended annually from December 31, 2007, to December 31, 2017. On November 16, 2017, our Chairman and Chief Executive Officer extended the due date of the funding commitment to December 31, 2018. Refer to Note 11.
During the year ended December 31, 2017, the Company had drawn the full funding amount under the initial agreement of $6.1 million plus additional advances of $7,963,349. On November 11, 2016, the Company and its Chairman and CEO entered into a Conversion Agreement pursuant to which $6,100,000 of principal and accrued but unpaid interest due him for working capital advanced to the Company as described in Notes 11 and 15 was converted into 20,333,333 shares of the Company's common stock at a conversion price of $0.30 per share in full satisfaction of such amount.
Additionally, the Company had unsecured loans outstanding from a former member of the board of directors who is also a significant stockholder, totaling $100,000 at December 31, 2016. The notes bear interest at a rate of 5% per annum and are due upon demand. During the year ended December 31, 2017, we repaid him $50,000 and in addition, he forgave $50,000 and accrued interest of $2,664. The forgiveness was treated as a capital contribution. In November 2017, the Company received an additional loan in the amount of $25,000 from this same former member of the Board of Directors. The loan bears interest at a rate of 5% per annum and is due December 31, 2018. Refer to Note 11.
F-18
PURADYN FILTER TECHNOLOGIES INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
DECEMBER 31, 2017 AND 2016
In November 2017, the Company received an additional loan in the amount of $25,000 from this same former member of the Board of Directors. The loan bears interest at a rate of 5% per annum and is due December 31, 2018.
On October 20, 2009, the Company entered into a consulting agreement with Boxwood Associates, Inc., whereby the Company pays $2,000 monthly for management and strategic development services performed. The contract remains in effect until terminated by either party providing 30 days written notice. During each of 2017 and 2016 we paid Boxwood Associates, Inc. $24,000 under this agreement. A former member of our board of directors is President of Boxwood Associates, Inc.
18. Major Customers
There are concentrations of credit risk with respect to accounts receivables due to the amounts owed by two customers at December 31, 2017 whose balances each represented approximately 53%, and 30%
,
for a total of 83% of total accounts receivables. There are concentrations of credit risk with respect to accounts receivables due to the amounts owed by three customers at December 31, 2016 whose balances each represented approximately 50%, 18%, and
13%
,
for a total of 81% of total accounts receivables. During the year ended December 31, 2017 sales from three customers represented 36%, 16% and 12% for a total of 64% of sales. During the year ended December 31, 2016 sales from three customers represented 24%, 18% and 15% for a total of 57% of sales. The loss of business from one or a combination of the Company’s significant customers, or an unexpected deterioration in their financial condition, could adversely affect the Company’s operations.
19. Subsequent Events
From January 1, 2018 through April 9, 2018, the Company received additional loans in the amount of $200,000 from the Company’s Chairman and CEO, as advances for working capital needs. The loans bear interest at the BBA Libor Daily Floating Rate plus 1.4 points.
Subsequent to December 31, 2017, the Company received a short-term advance from related party in the amount of $250,000 for working capital needs. The short-term advance is non-interest bearing and due on demand.
F-19